Bioprocessing - Upstream & Downstream

Real-time monitoring and analysis of biologics during manufacturing is within reach

The increasing demand for disposable technologies puts pressure on suppliers to up their game

Biopharma manufacturing continues to advance and the demand for new innovations is constant.

Can high density cryopreservation allow biopharma manufacturers to buy back time?

Synthetic biology could help to re-write the rules of biopharma production.

We track the rapid rise of single use systems – and explore their role in the biomanufacturing facility of the future

Continuous manufacturing technologies are seeing increased industry uptake, particularly perfusion systems and, increasingly, intensified perfusion.

What separates a good model from a bad model in bioprocess development?

We investigate the advantages and limitations of microcalorimetry in biopharma.

Is there a future for Protein A in affinity chromatography?